Life Expectancy in Cirrhosis
Patients with compensated cirrhosis have a median survival exceeding 12 years, while those with decompensated cirrhosis have a median survival of approximately 1.8-2 years. 1, 2
Survival by Disease Stage
Compensated Cirrhosis
- Median survival exceeds 12 years in patients without clinically overt complications 1, 2
- 5-year survival is approximately 80-90% depending on Child-Pugh class A (score 5-6) 3
- Patients with Child-Pugh class B (score 7-9) have approximately 80% 5-year survival 3
- Nearly five-fold increased risk of death compared to the general population (hazard ratio 4.7) 4
- Progression to decompensation occurs at 5-7% per year, with about 50% developing ascites within 10 years 2
Decompensated Cirrhosis
- Median survival drops to 1.8-2 years once decompensation occurs 1, 2
- 5-year survival is only 20-50% after development of complications 3
- Child-Pugh class C patients (score ≥10) have less than one-third surviving 1 year while awaiting transplantation 3
- Nearly 10-fold increased risk of death compared to the general population (hazard ratio 9.7) 4
- 5-year survival is 14-35% in patients with decompensated cirrhosis 5
Survival by Specific Complications
Ascites
- Median survival of 1.1 years after onset 6
- 1-year survival rate of 60% and 2-year survival of 45% 2
- Annual incidence of spontaneous bacterial peritonitis is 11% in patients with ascites 6
Hepatic Encephalopathy
- Median survival of 0.92 years after onset 6
- 5-year mortality exceeds 80% when presenting with multiple complications 7
Hepatorenal Syndrome
- Median survival less than 2 weeks for type I hepatorenal syndrome 3
- Annual incidence is 8% in patients with ascites 6
- Less than 50% survive 1 year after developing spontaneous bacterial peritonitis 3
Variceal Hemorrhage
- 5-year mortality of 20% when presenting as isolated complication 7
- 5-year mortality exceeds 80% when associated with other complications 7
- Recurrent hemorrhage occurs in 60% of untreated patients within 1-2 years 7
Prognostic Factors Affecting Survival
Disease Severity Markers
- MELD score provides continuous risk stratification: scores 6-40 correlate with 3-month survival from 90% to 7% 3
- HVPG >20 mm Hg is associated with poor outcomes, particularly in Child-Pugh C patients 7
- Presence of clinically significant portal hypertension (HVPG ≥10 mm Hg) increases risk of decompensation and hepatocellular carcinoma 7
Etiology-Specific Considerations
- Alcoholic cirrhosis confers worse prognosis than non-alcohol-related cirrhosis both in the first year and subsequently 4
- Continued alcohol abuse is a significant predictor of death risk in decompensated disease 8
- HBsAg positivity is an independent predictor of death risk in both compensated and decompensated patients 8
Comorbidity Impact
- Presence of 1 chronic disease increases mortality risk 2.5-fold, 2 diseases 3.3-fold, and 3 diseases 4.5-fold 9
- Compensated cirrhosis with 3 chronic diseases has similar survival (67.7%) to decompensated cirrhosis with 1-3 conditions (61.9%-63.9%) 9
- Obesity, diabetes, and cardiovascular disease independently worsen prognosis 7, 9
Hepatocellular Carcinoma Risk
- Annual incidence of 1-4% in patients with cirrhosis 10, 6
- Annual incidence of 2-5% once cirrhosis is established 5
- 5-year survival approximately 20% after HCC diagnosis 6
- HCC accounts for 22% of deaths in cirrhotic patients 5
Clinical Caveats
Age and functional status matter more than arbitrary cutoffs. While surveillance for HCC may not be cost-effective above age 70 in cirrhosis or age 60 in advanced fibrosis based on remaining life expectancy, the presence of comorbidities compromising treatment options (severe heart, lung, or kidney disease, frailty) should guide decisions rather than age alone 11
Bacterial infections significantly worsen prognosis. The presence of bacterial infections is associated with poor outcomes in variceal hemorrhage and can precipitate acute-on-chronic liver failure with 30-50% mortality at 28 days 7, 10
The stage of "further decompensation" (second decompensating event, recurrent ascites requiring large-volume paracentesis, recurrent variceal hemorrhage, recurrent encephalopathy) represents a distinct prognostic category with particularly poor outcomes 1